Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects
Status:
Completed
Trial end date:
2018-05-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK), safety and tolerability
and pharmacodynamics (PD) of lanadelumab in healthy adult Japanese subjects and matched
non-Hispanic healthy adult Caucasian subjects.